Comparison of cystatin C and Beta-2-microglobulin kinetics in children on maintenance hemodialysis

Hemodialysis International

Volumn 17, Issue SUPPL1, 2013, Pages

  Marsenic, Olivera ^a   Wierenga, Andrea ^a   Wilson, Donna R ^a   Anderson, Michael ^b   Shrivastava, Tripti ^a   Simon, Garfield A ^a   Beck, Anne M ^a   Swanson, Tiffany J ^a   Studnicka, Kathleen ^a   Elberg, Dorit ^a   Singh, Nisha S ^a   Couloures, Kevin ^a   Henry, Dwayne ^a   Turman, Martin A ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Beta 2 microglobulin; Cystatin C; Hemodialysis adequacy; Pediatric hemodialysis

Indexed keywords

BETA 2 MICROGLOBULIN; CYSTATIN C;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KINETICS; MAINTENANCE THERAPY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; ULTRAFILTRATION;

BETA-2-MICROGLOBULIN; CYSTATIN C; HEMODIALYSIS ADEQUACY; PEDIATRIC HEMODIALYSIS;

ADOLESCENT; AGE FACTORS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CHILD; CYSTATIN C; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS;

EID: 84885707378     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12083     Document Type: Article

References (29)

1. Kuragano T, Kida A, Furuta M, etal. The impact of beta2-microglobulin clearance on the risk factors of cardiovascular disease in hemodialysis patients. ASAIO J. 2010; 56:326-332.
2. Liabeuf S, Lenglet A, Desjardins L, etal. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Kidney Int. 2012; 82:1297-1303.
3. Fischbach M, Fothergill H, Zaloszyc A, Menouer S, Terzic J. Intensified daily dialysis: The best chronic dialysis option for children. Semin Dial. 2011; 24:640-644.
4. Fischbach M, Fothergill H, Zaloszyc A, Seuge L. Hemodiafiltration: The addition of convective flow to hemodialysis. Pediatr Nephrol. 2012; 27:351-356.
5. Fischbach M, Hamel G, Koehl C, Geisert J. Beta-2-microglobulin in hemodiafiltered children: Long-term efficiency follow-up. Nephron. 1989; 53:110-114.
6. Lindstrom V, Grubb A, Hegbrant MA, Christensson A. Different elimination patterns of b-trace protein, β2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Scand J Clin Lab Invest. 2008; 68:685-691.
7. Leypoldt JK. Kinetics of β2-microglobulin and phosphate during hemodialysis: Effects of treatment frequency and duration. Semin Dial. 2005; 18:401-408.
8. Cheung AK. Biocompatibility of hemodialysis membranes. J Am Soc Nephrol. 1990; 1:150-161.
9. Dixit MP, CabansagMR PJ, GreiferI SDM. Serum beta2-microglobulin and immunoglobulin levels in young hemodialysis patients. Pediatr Nephrol. 1999; 13:139-142.
10. Eloot S, Biesen WV, Vanholder RA. Sad but forgotten truth: The story of slow-moving solutes in fast hemodialysis. Semin Dial. 2012; 25:505-509.
11. Mayer G, Thum J, Woloszczuk W, Graf H. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures. Am J Nephrol. 1988; 8:280-284.
12. Park JS, Kim GH, Kang CM, Lee CH. Application of Cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules. Korean J Intern Med. 2010; 25:77-81.
13. Huang SH, Filler G, Yasin A, Lindsay RM. Cystatin C reduction ratio depends on normalized blood liters processed and fluid removal during hemodialysis. Clin J Am Soc Nephrol. 2011; 6:319-325.
14. Al-Malki N, Heidenheim PA, Filler G, Yasin A, Lindsay RM. Cystatin C levels in functionally anephric patients undergoing dialysis: The effect of different methods and intensities. Clin J Am Soc Nephrol. 2009; 4:1606-1610.
15. Campo A, Lanfranco G, Gramaglia L, Goia F, Cottino R, Giusto V. Could plasma cystatin C be useful as a marker of hemodialysis low molecular weight proteins removal. Nephron Clin Pract. 2004; 98:c79-c82.
16. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol. 1993; 4:1205-1213.
17. KDOQI Clinical practice guidelines for hemodialysis adequacy. Guideline 3. Methods for postdialysis blood sampling. Am J Kidney Dis. 2006; 48:S24-S27.
18. Bacchetta J, Cochat P, Rognant N, Ranchin B, Hadj-Aissa A, Dubourg L. Which creatinine and Cystatin C equations can be reliably used in children. Clin J Am Soc Nephrol. 2011; 6:552-560.
19. Andersen TB, Jødal L, Boegsted M, etal. GFR prediction from Cystatin C and creatinine in children: Effect of including body cell mass. Am J Kidney Dis. 2011; 59:50-57.
20. Sharma AP, Yasin A, Garg AX, Filler G. Diagnostic accuracy of Cystatin C-based eGFR equations at different GFR levels in children. Clin J Am Soc Nephrol. 2011; 6:1599-1608.
21. Sharma AP, Kathiravelu A, Nadarajah R, Yasin A, Filler G. Body mass does not have a clinically relevant effect on cystatin C eGFR in children. Nephrol Dial Transplant. 2009; 24:470-474.
22. Zaffanello M, Franchini M, Fanos V. Is serum Cystatin-C a suitable marker of renal function in children. Ann Clin Lab Sci. 2007; 37:233-240.
23. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest. 1996; 56:409-414.
24. Uji Y, Motomiya Y, Ando Y. Effect of heparin on conformation of the b2-microglobulin molecule. Ther Apher Dial. 2012; 16:159-162.
25. Macleod AM, Campbell M, Cody JD, etal. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. Cochrane Database Syst Rev. 2005; 20(3) CD003234.
26. Cheung AK, Rocco MV, Yan G, etal. Serum beta-2 microglobulin levels predict mortality in dialysis patients: Results of the HEMO study. J Am Soc Nephrol. 2006; 17:546-555.
27. Müller D, Zimmering M, Chan CT, McFarlane PA, PierratosA QU. Intensified hemodialysis regimens: Neglected treatment options for children and adolescents. Pediatr Nephrol. 2008; 23:1729-1736.
28. Goldstein SL, Silverstein DM, Leung JC, etal. Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis. Pediatr Nephrol. 2008; 23:129-135.
29. Marsenic O, Wierenga A, Wilson DR, etal. Cystatin C in children on chronic hemodialysis. Pediatr Nephrol. 2013; 28:647-653.